| 1 |
32479865 | Lack of antiviral activity of darunavir against SARS-CoV-2. | 2020 Aug |
1 |
| 2 |
32856282 | Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6. | 2020 Oct |
1 |
| 3 |
28569994 | Physiologically Based Pharmacokinetic Modeling for Predicting the Effect of Intrinsic and Extrinsic Factors on Darunavir or Lopinavir Exposure Coadministered With Ritonavir. | 2017 Oct |
4 |
| 4 |
28616684 | Influence of Ethanol on Darunavir Hepatic Clearance and Intracellular PK/PD in HIV-Infected Monocytes, and CYP3A4-Darunavir Interactions Using Inhibition and in Silico Binding Studies. | 2017 Sep |
1 |
| 5 |
26369773 | Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy. | 2016 Mar |
1 |
| 6 |
23441978 | Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial. | 2013 Aug |
1 |
| 7 |
19931478 | Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS. | 2010 Jan |
1 |
| 8 |
20861742 | Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans. | 2010 Dec 15 |
1 |
| 9 |
20978219 | Increased aripiprazole concentrations in an HIV-positive male concurrently taking duloxetine, darunavir, and ritonavir. | 2010 Nov |
1 |
| 10 |
19323590 | Darunavir: a review of its use in the management of HIV infection in adults. | 2009 |
3 |
| 11 |
18389894 | Darunavir: pharmacokinetics and drug interactions. | 2008 |
4 |
| 12 |
19195459 | [Pharmacological interactions with darunavir]. | 2008 Oct |
1 |
| 13 |
17713972 | Clinical pharmacokinetics of darunavir. | 2007 |
2 |